Skip to main content
Fig. 6 | Respiratory Research

Fig. 6

From: A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

Fig. 6

Treatment effect on rate of AECOPD by baseline neutrophil count (mITT population). Exacerbation rate ratio and 90% confidence interval estimated by bisecting the data at each value of the baseline blood neutrophils and analysing the data above and below the cut point using a negative binomial regression adjusting for treatment, background therapy and history of exacerbations

AECOPD acute exacerbations of chronic obstructive pulmonary disease, CI confidence interval, mITT modified intention-to-treat, SE standard error

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us